Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.
about
Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseasesBridge between neuroimmunity and traumatic brain injuryEnabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicinesGDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse modelMacrophages offer a paradigm switch for CNS delivery of therapeutic proteins.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Agile delivery of protein therapeutics to CNSCo-opting biology to deliver drugsExosomes as drug delivery vehicles for Parkinson's disease therapyNano-enabled delivery of diverse payloads across complex biological barriers.Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.Neuropharmacologic Approaches to Restore the Brain's Microenvironment.Macrophage-based cell therapies: The long and winding roadMacrophage-based therapeutic strategies in regenerative medicine.Clodronate Improves Survival of Transplanted Hoxb8 Myeloid Progenitors with Constitutively Active GMCSFR in Immunocompetent Mice.Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.Insights on Localized and Systemic Delivery of Redox-Based Therapeutics.Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment.
P2860
Q21133553-C55271CA-0806-486A-8D12-6920C9D74941Q26827612-8AE0D6D8-9024-42AB-8D5E-29691AE17AADQ26850868-03D88A80-D0FF-4EF8-8E69-72CB0E16C85AQ28543023-CBAC12C7-E977-44F0-B22E-B267627C2911Q33631069-BDDAAEBB-996B-447F-832F-B5880DBCBBB4Q34079604-F5CE32A8-A4A0-4C82-B934-D36CCC21B559Q34079647-C1E4638E-4F33-400A-9845-16F227863164Q34424045-CC57446E-8AEB-44EC-A21C-D54E95E426C3Q35602589-C4FD0E01-C9BB-4637-91F6-B3369855BE9BQ36307467-EB4D337B-1753-4D11-8590-353332B222D2Q36369061-A7E5DF17-87E9-4CC7-910F-DF61B2776196Q38787356-5E22FDF2-8AC4-4179-AAA1-DE92C6F0ED71Q38879533-BA72F497-9501-4619-AEB7-C7094E375345Q38898549-35CFB2F3-818B-4E30-96A0-5F9F215C59EEQ39319066-8195A3C4-3FA2-4DD4-9CB4-4E7CB60D5CD3Q42373508-663C3DD1-8094-480C-9FD2-9B75C5270131Q47824357-20D67E0A-D88E-4227-B38E-607DF55A4F2BQ52653941-6EE11F8A-B1CB-4CB5-8EE6-4E4CB0F24134Q52720174-8384F3E9-9BC4-4C51-9BC0-82F961AA7C90Q54958949-B8C02095-F6F2-402D-87F7-1C4BCE2BA7BB
P2860
Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@ast
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@en
type
label
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@ast
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@en
prefLabel
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@ast
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@en
P2093
P2860
P356
P1476
Active Targeted Macrophage-med ...... Models of Parkinson's Disease.
@en
P2093
Alexander V Kabanov
Anna Dunaevsky
Benjamin C Reiner
Elena V Batrakova
Howard E Gendelman
Matthew J Haney
R Lee Mosley
Vivek Mahajan
Yuling Zhao
P2860
P356
10.4172/2157-7439.S4-003
P577
2011-09-01T00:00:00Z